OREM, UT--(Marketwire - May 24, 2011) - Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, announced that the Cryometrix T-150 ULT freezer is making gains in the stem cell and tissue repository market because of superior performance compared to existing freezer products.
The Cryometrix T-150 is being considered as a replacement for mechanical chest freezers in the stem cell and tissue repository market not only for its excellent temperature uniformity, but also ergonomic factors. “The stem cell application would utilize the very lowest temperatures of the wide T-150 temperature range, replacing problematic mechanical refrigeration units. The interesting point here is due to the elimination of ice buildup and upright design, our customer acknowledges the T-150 technology to be a significant safety improvement for lab personnel. Back injuries and loss of work time caused by traditional chest freezers is simply solved by the T-150’s upright design while also improving the internal temperature uniformity. We are looking forward to assisting the lab personnel in eliminating injuries and loss of work time,” said Dr. Boyd Bowdish, Principal Scientist at Reflect Scientific.
The Cryometrix T-150 ULT freezer uses the Reflect Scientifics revolutionary patented liquid nitrogen cooling technology. This technology does not use mechanical compressors or environmentally unfriendly refrigerants. The benefit is a significant reduction in operating costs and superior cooling capabilities.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.
Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.
Contact:
Thomas Tait
Vice President
719-357-5878
